220 related articles for article (PubMed ID: 12412164)
1. The diagnostic accuracy of the age-adjusted and prostate volume-adjusted biopsy method in males with prostate specific antigen levels of 4.1-10.0 ng/mL.
Ito K; Ohi M; Yamamoto T; Miyamoto S; Kurokawa K; Fukabori Y; Suzuki K; Yamanaka H
Cancer; 2002 Nov; 95(10):2112-9. PubMed ID: 12412164
[TBL] [Abstract][Full Text] [Related]
2. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations.
Gohji K; Nomi M; Egawa S; Morisue K; Takenaka A; Okamoto M; Ohori M; Fujii A
Cancer; 1997 May; 79(10):1969-76. PubMed ID: 9149025
[TBL] [Abstract][Full Text] [Related]
3. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
[TBL] [Abstract][Full Text] [Related]
4. Transperineal ultrasound-guided 12-core systematic biopsy of the prostate for patients with a prostate-specific antigen level of 2.5-20 ng/ml in Japan.
Yamamoto S; Kin U; Nakamura K; Hamano M; Nishikawa Y; Takenouchi T; Maruoka M
Int J Clin Oncol; 2005 Apr; 10(2):117-21. PubMed ID: 15864697
[TBL] [Abstract][Full Text] [Related]
5. Does transrectal ultrasound guided eight-core prostate biopsy improve cancer detection rates in patients with prostate-specific antigen levels of 4.1-10 ng/mL?
Yamamoto S; Ito T; Aizawa T; Noda K; Umezu K; Ohtsuru N; Hata K
Int J Urol; 2004 Jun; 11(6):386-91. PubMed ID: 15157207
[TBL] [Abstract][Full Text] [Related]
6. Extensive biopsy using a combined transperineal and transrectal approach to improve prostate cancer detection.
Watanabe M; Hayashi T; Tsushima T; Irie S; Kaneshige T; Kumon H
Int J Urol; 2005 Nov; 12(11):959-63. PubMed ID: 16351651
[TBL] [Abstract][Full Text] [Related]
7. Indications for extended 14-core transrectal ultrasound-guided prostate biopsy.
Uno H; Nakano M; Ehara H; Deguchi T
Urology; 2008 Jan; 71(1):23-7. PubMed ID: 18242358
[TBL] [Abstract][Full Text] [Related]
8. No reason for immediate repeat sextant biopsy after negative initial sextant biopsy in men with PSA level of 4.0 ng/mL or greater (ERSPC, Rotterdam).
Roobol MJ; van der Cruijsen IW; Schröder FH
Urology; 2004 May; 63(5):892-7; discussion 897-9. PubMed ID: 15134973
[TBL] [Abstract][Full Text] [Related]
9. Value of prostate volume measurement using transabdominal ultrasonography for the improvement of prostate-speci fi c antigen-based cancer detection.
Kobayashi T; Kawahara T; Nishizawa K; Ogura K; Mitsumori K; Ide Y
Int J Urol; 2005 Oct; 12(10):881-5. PubMed ID: 16323981
[TBL] [Abstract][Full Text] [Related]
10. Volume-adjusted prostate-specific antigen (PSA) variables in detecting impalpable prostate cancer in men with PSA levels of 2-4 ng/mL: transabdominal measurement makes a significant contribution.
Kobayashi T; Kawahara T; Nishizawa K; Ogura K; Mitsumori K; Ide Y
BJU Int; 2005 Jun; 95(9):1245-8. PubMed ID: 15892809
[TBL] [Abstract][Full Text] [Related]
11. [Usefulness and predictive value of PSA density, adjusted by transition zone volume, in men with PSA levels between 2 and 4 ng/ml].
Janane A; Hajji F; Ismail T; Jawad C; Elondo JC; Dakka Y; Ghadouane M; Ameur A; Abbar M; Albouzidi A
Actas Urol Esp; 2012 Feb; 36(2):93-8. PubMed ID: 22188752
[TBL] [Abstract][Full Text] [Related]
12. [Questionnaire based evaluation of prostate biopsy complication comparing different bioptic schemes].
Damiano R; Oliva A; Cantiello F; Esposito C; Perdonà S; De Sio M; Bitonti M; Sacco R; D'Armiento M
Arch Ital Urol Androl; 2003 Mar; 75(1):40-5. PubMed ID: 12741345
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen.
Hambrock T; Somford DM; Hoeks C; Bouwense SA; Huisman H; Yakar D; van Oort IM; Witjes JA; Fütterer JJ; Barentsz JO
J Urol; 2010 Feb; 183(2):520-7. PubMed ID: 20006859
[TBL] [Abstract][Full Text] [Related]
14. Transrectal ultrasound-guided transperineal 14-core systematic biopsy detects apico-anterior cancer foci of T1c prostate cancer.
Kawakami S; Kihara K; Fujii Y; Masuda H; Kobayashi T; Kageyama Y
Int J Urol; 2004 Aug; 11(8):613-8. PubMed ID: 15285751
[TBL] [Abstract][Full Text] [Related]
15. Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with psa levels between 2.6 and 10.0 ng/mL.
Castro HAS; Iared W; Santos JEM; Solha RS; Shigueoka DC; Ajzen SA
Int Braz J Urol; 2018; 44(4):709-716. PubMed ID: 29697929
[TBL] [Abstract][Full Text] [Related]
16. [Early diagnosis of prostate carcinoma with reference to the density of prostate-specific antigen].
Schmid HP; Ravery V; Toublanc M; Boccon-Gibod L
Schweiz Med Wochenschr; 1996 Sep; 126(36):1530-5. PubMed ID: 8927956
[TBL] [Abstract][Full Text] [Related]
17. [Can indexes based on PSA determine which patients should undergo repeated ultrasound-guided transrectal prostatic biopsy? Study on 546 patients who underwent repeated biopsy].
Rodríguez-Patrón Rodríguez R; Mayayo Dehesa T; González Galán A; Zuccarino AL; García González R; Cuesta Roca C
Arch Esp Urol; 2002 Dec; 55(10):225-34. PubMed ID: 12611220
[TBL] [Abstract][Full Text] [Related]
18. Impact of additional sampling in the TRUS-guided biopsy for the diagnosis of prostate cancer.
Stamatiou K; Alevizos A; Karanasiou V; Mariolis A; Mihas C; Papathanasiou M; Bovis K; Sofras F
Urol Int; 2007; 78(4):313-7. PubMed ID: 17495488
[TBL] [Abstract][Full Text] [Related]
19. [Early diagnosis of prostatic carcinoma by random biopsies in 60 patients clinically negative but with PSA greater than 8.9 ng/ml].
Bianchi A; Bottanelli A; Baroni G; Rovellini P; Sciaraffia G; Toia G; Marcelli G
Arch Ital Urol Androl; 1997 Dec; 69(5):313-8. PubMed ID: 9477617
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng./ml. Prostate specific antigen.
Lodding P; Aus G; Bergdahl S; Frösing R; Lilja H; Pihl CG; Hugosson J
J Urol; 1998 Mar; 159(3):899-903. PubMed ID: 9474178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
